688389.SH
普门科技
SSE · Healthcare · Medical - Specialties · CN
CNY 10.80
−3.23%Year over year
Reported trailing growth
- Revenue
- +2.4%
- EBITDA
- —
- EBIT
- -47.1%
- EPS
- -44.3%
- Free cash flow
- +9.7%
- Operating cash flow
- +13.6%
Forward estimates
Based on analyst estimates
- Revenue
- -68.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.8%
- EBITDA
- -7.8%
- EBIT
- -11.3%
- Net income
- -9.9%
- EPS
- -10.5%
- Free cash flow
- +30.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026